Explore the details of the Orion Corporation V. Alembic Pharmaceuticals Limited case under case number 1:25cv00825 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25cv00825
Filing Date
Jul 3, 2025
Cause of Action
Patent Infringement
Status
-
Case Link
View Case
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Bayer Consumer Care AG -
Alembic Pharmaceuticals Limited -
Orion Corporation -

Patents Involved in the Case

This case involves 5 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 3, 2025Summons Issued as to Alembic Pharmaceuticals Limited on 7/3/2025; Alembic Pharmaceuticals, Inc. on 7/3/2025. (Attachments: # 1 Summons Issued)(scs) (Entered: 07/03/2025)PACER Document
Jul 3, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc. filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation. (Attachments: # 1 Rule 7.1)(scs) (Entered: 07/03/2025)PACER Document
Jul 3, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,010,530 B2; 10,383,853 B2; 10,835,515 B2; 11,168,058 B2. (scs) (Entered: 07/03/2025)PACER Document
Jul 3, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 21, 2025. Date of Expiration of Patent: 01/28/2036, 02/27/2038.Thirty Month Stay Deadline: 11/21/2027. (scs) (Entered: 07/03/2025)PACER Document
Jul 3, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 07/03/2025)PACER Document
Jul 3, 2025COMPLAINT for Patent Infringement filed against Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4725739.) - filed by Orion Corporation, Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(scs) (Entered: 07/03/2025)PACER Document